When you drive past Methuen Memorial Music Hall in Methuen, Massachusetts, you might think it's an old city building. But it was built by a very wealthy local man just to house one spectacular ...

As part of its efforts to strengthen the country’s organ transplant system, the US Department of Health and Human Services says it is moving to decertify a major organ procurement organization – ...

The U.S. is developing new safeguards for the organ transplant system after a government investigation found a Kentucky group continued preparations for organ donation by some patients who showed ...

As a new report claims that premature organ transplants have endangered donors, HHS Sec. Robert F. Kennedy Jr. has announced plans for a new initiative to reform the system. Several families have ...

Site plans for a towering residential project in downtown Sarasota are officially in the books. The Adagio, a condominium project for 172 residential units and commercial space across two towers, ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? If you’ve learned anything from the health and fitness industry over the past ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Photo submitted to the Times Observer Hunter Peterson is pictured at an organ. [email protected] Hunter Peterson will be the featured soloist for Sunday’s Warren Philharmonic Mother’s Day ...

Adagio Medical Holdings Inc (NASDAQ:ADGM) shares are trading higher by 124% to $2.07 during Thursday’s session after the FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.

Soon after 2024 became 2025, we learned some troubling but not exactly shocking news: The Macy’s store at 1300 Market Street will be closing. It’s not just Philadelphia — Macy’s announced in December ...

Cryoablation devicemaker Adagio Medical has opted to pause the European launch of one of its catheters, currently in the early stages, and will instead focus efforts on obtaining approval in the U.S.